Atria Investments LLC Tiziana Life Sciences LTD Transaction History
Atria Investments LLC
- $7.49 Billion
- Q4 2024
A detailed history of Atria Investments LLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Atria Investments LLC holds 12,718 shares of TLSA stock, worth $10,810. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,718Holding current value
$10,810% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TLSA
# of Institutions
31Shares Held
992KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA246KShares$208,8630.0% of portfolio
-
Morgan Stanley New York, NY111KShares$94,2060.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$89,5600.0% of portfolio
-
Zhang Financial LLC93.2KShares$79,2080.0% of portfolio
-
Kovitz Investment Group Partners, LLC79.4KShares$67,4600.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $86.9M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...